PMC:7127386 / 8823-8941 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"232","span":{"begin":59,"end":88},"obj":"Disease"}],"attributes":[{"id":"A232","pred":"tao:has_database_id","subj":"232","obj":"MESH:D019698"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Ribavirin guanosine analogue FDA approved for treatment of chronic hepatitis C infection 36791-04-5 \u003e100 500 \u003e500 \u003e500"}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T45","span":{"begin":59,"end":78},"obj":"Disease"},{"id":"T47","span":{"begin":59,"end":76},"obj":"Disease"},{"id":"T48","span":{"begin":79,"end":88},"obj":"Disease"}],"attributes":[{"id":"A45","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005231"},{"id":"A46","pred":"mondo_id","subj":"T45","obj":"http://purl.obolibrary.org/obo/MONDO_0005354"},{"id":"A47","pred":"mondo_id","subj":"T47","obj":"http://purl.obolibrary.org/obo/MONDO_0002251"},{"id":"A48","pred":"mondo_id","subj":"T48","obj":"http://purl.obolibrary.org/obo/MONDO_0005550"}],"text":"Ribavirin guanosine analogue FDA approved for treatment of chronic hepatitis C infection 36791-04-5 \u003e100 500 \u003e500 \u003e500"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T129","span":{"begin":10,"end":19},"obj":"Chemical"}],"attributes":[{"id":"A129","pred":"chebi_id","subj":"T129","obj":"http://purl.obolibrary.org/obo/CHEBI_16750"}],"text":"Ribavirin guanosine analogue FDA approved for treatment of chronic hepatitis C infection 36791-04-5 \u003e100 500 \u003e500 \u003e500"}

{"project":"LitCovid-sentences","denotations":[{"id":"T52","span":{"begin":0,"end":118},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Ribavirin guanosine analogue FDA approved for treatment of chronic hepatitis C infection 36791-04-5 \u003e100 500 \u003e500 \u003e500"}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T2","span":{"begin":59,"end":76},"obj":"Phenotype"}],"attributes":[{"id":"A2","pred":"hp_id","subj":"T2","obj":"http://purl.obolibrary.org/obo/HP_0200123"}],"text":"Ribavirin guanosine analogue FDA approved for treatment of chronic hepatitis C infection 36791-04-5 \u003e100 500 \u003e500 \u003e500"}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T241","span":{"begin":34,"end":43},"obj":"CHEBI:28201;CHEBI:28201;DG_29"},{"id":"T242","span":{"begin":101,"end":111},"obj":"SP_7"},{"id":"T243","span":{"begin":112,"end":117},"obj":"NCBITaxon:10239"}],"text":"Ribavirin guanosine analogue FDA approved for treatment of chronic hepatitis C infection 36791-04-5 \u003e100 500 \u003e500 \u003e500"}